Francis Remerand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Francis Remerand has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
J. Fusciardi
Pôle anesthésie réanimation SAMU, université François-Rabelais, CHRU de Tours, Tours, France
8 shared publicationsM. Laffon
Pôle anesthésie réanimation SAMU, université François-Rabelais, CHRU de Tours, Tours, France
7 shared publicationsC. Couvret
6 shared publicationsA. Baud
3 shared publications- Jacques Fusciardi
CHRU de Tours, Department of Anaesthesiology and Intensive Care, Tours, France
3 shared publications L. Favard
3 shared publications
Latest Publications
- 18 March 2023
- Published by Springer Nature in Pediatric Radiology
- Vol. 53 (8) , 1669-1674
French survey of sedation practices for pediatric magnetic resonance and computed tomography imaging
Background Pediatric magnetic resonance imaging (MRI) and computed tompgraphy (CT) require patient immobility and therefore often require sedation or general anesthesia of patients. Consensus on these procedures is lacking in France. Objective Thus, the aim of this study was to describe the current sedation practices for pediatric MRI and CT in France. Material and methods From January 2019 to December 2019, an online questionnaire was delivered by electronic mail to a representative radiologist in 60 pediatric radiology centers registered by the French-speaking pediatric and prenatal imaging society. Questions included protocols, drugs used, monitoring and side effects. Results Representatives of 40 of the 60 (67%) radiology centers responded to the survey. Among them, 31 performed sedation including 17 (55%) centers where radiologists performed sedation without anesthesiologists present during the procedure. The premedication drugs were hydroxyzine (n = 8, 80%) and melatonin (n = 2, 20%), Sedation drugs used for children ages 0 to 6 years old were pentobarbital (n = 9, 60%), midazolam (n = 2, 13%), chloral hydrate (n = 2, 13%), diazepam (n = 1, 6.5%) and chlorpromazine (n = 1, 6.5%). A written sedation protocol was available in 10/17 (59%) centers. In 6/17 (35%) centers, no monitoring was used during the procedures. Blood pressure monitoring and capnography were rarely used (< 10%) and post-sedation monitoring was heterogeneous. No life-threatening adverse effect was reported, but 6 centers reported at least one incident per year. Conclusion For half of the responding radiology centers, radiologists performed sedation alone in agreement with the local anesthesiology team. Sedation procedures and monitoring were heterogenous among centers. Adjustment and harmonization of the practices according to the capacity of each center may be useful.
- 18 March 2023
- Published by Springer Nature in Pediatric Radiology
- Vol. 53 (8) , 1669-1674
French survey of sedation practices for pediatric magnetic resonance and computed tomography imaging
Background Pediatric magnetic resonance imaging (MRI) and computed tompgraphy (CT) require patient immobility and therefore often require sedation or general anesthesia of patients. Consensus on these procedures is lacking in France. Objective Thus, the aim of this study was to describe the current sedation practices for pediatric MRI and CT in France. Material and methods From January 2019 to December 2019, an online questionnaire was delivered by electronic mail to a representative radiologist in 60 pediatric radiology centers registered by the French-speaking pediatric and prenatal imaging society. Questions included protocols, drugs used, monitoring and side effects. Results Representatives of 40 of the 60 (67%) radiology centers responded to the survey. Among them, 31 performed sedation including 17 (55%) centers where radiologists performed sedation without anesthesiologists present during the procedure. The premedication drugs were hydroxyzine (n = 8, 80%) and melatonin (n = 2, 20%), Sedation drugs used for children ages 0 to 6 years old were pentobarbital (n = 9, 60%), midazolam (n = 2, 13%), chloral hydrate (n = 2, 13%), diazepam (n = 1, 6.5%) and chlorpromazine (n = 1, 6.5%). A written sedation protocol was available in 10/17 (59%) centers. In 6/17 (35%) centers, no monitoring was used during the procedures. Blood pressure monitoring and capnography were rarely used (< 10%) and post-sedation monitoring was heterogeneous. No life-threatening adverse effect was reported, but 6 centers reported at least one incident per year. Conclusion For half of the responding radiology centers, radiologists performed sedation alone in agreement with the local anesthesiology team. Sedation procedures and monitoring were heterogenous among centers. Adjustment and harmonization of the practices according to the capacity of each center may be useful.
- Open Access
- 25 November 2020
- Published by Springer Nature in Trials
- Vol. 21 (1) , 1-10
The A2B trial, antibiotic prophylaxis for excision-graft surgery in burn patients: a multicenter randomized double-blind study
Background: The indication for antibiotic prophylaxis in burn patients remains highly controversial, with no consensus having been reached. The objective of antibiotic prophylaxis is to reduce the risk of postoperative local and systemic infections. Burn surgery is associated with a high incidence of bacteremia, postoperative infections, and sepsis. However, antibiotic prophylaxis exposes patients to the risk of selecting drug-resistant pathogens as well as to the adverse effects of antibiotics (i.e., Clostridium difficile colitis). The lack of data precludes any strong international recommendations regarding perioperative prophylaxis using systemic antibiotics in this setting. The goal of this project is therefore to determine whether perioperative systemic antibiotic prophylaxis can reduce the incidence of postoperative infections in burn patients. Methods: The A2B trial is a multicenter (10 centers), prospective, randomized, double-blinded, placebo-controlled study. The trial will involve the recruitment of 506 adult burn patients with a total body surface area (TBSA) burn of between 5 and 40% and requiring at least one excision-graft surgery for deep burn injury. Participants will be randomized to receive antibiotic prophylaxis (antibiotic prophylaxis group) or a placebo (control group) 30 min before the incision of the first two surgeries. The primary outcome will be the occurrence of postoperative infections defined as postoperative sepsis and/or surgical site infection and/or graft lysis requiring a new graft within 7 days after surgery. Secondary outcomes will include mortality at day 90 postrandomization, skin graft lysis requiring a new graft procedure, postoperative bacteremia (within 48 h of surgery), postoperative sepsis, postoperative surgical site infection, number of hospitalizations until complete healing (> 95% TBSA), number of hospitalization days living without antibiotic therapy at day 28 and day 90, and multiresistant bacterial colonization or infection at day 28 and day 90. Discussion: The trial aims to provide evidence on the efficacy and safety of antibiotic prophylaxis for excision-graft surgery in burn patients. Trial registration: ClinicalTrials.gov NCT04292054. Registered on 2 March 2020
- 25 November 2020
- Published by Springer Nature in Trials
- Vol. 21 (1) , 1-10
Open AccessThe A2B trial, antibiotic prophylaxis for excision-graft surgery in burn patients: a multicenter randomized double-blind study
Background: The indication for antibiotic prophylaxis in burn patients remains highly controversial, with no consensus having been reached. The objective of antibiotic prophylaxis is to reduce the risk of postoperative local and systemic infections. Burn surgery is associated with a high incidence of bacteremia, postoperative infections, and sepsis. However, antibiotic prophylaxis exposes patients to the risk of selecting drug-resistant pathogens as well as to the adverse effects of antibiotics (i.e., Clostridium difficile colitis). The lack of data precludes any strong international recommendations regarding perioperative prophylaxis using systemic antibiotics in this setting. The goal of this project is therefore to determine whether perioperative systemic antibiotic prophylaxis can reduce the incidence of postoperative infections in burn patients. Methods: The A2B trial is a multicenter (10 centers), prospective, randomized, double-blinded, placebo-controlled study. The trial will involve the recruitment of 506 adult burn patients with a total body surface area (TBSA) burn of between 5 and 40% and requiring at least one excision-graft surgery for deep burn injury. Participants will be randomized to receive antibiotic prophylaxis (antibiotic prophylaxis group) or a placebo (control group) 30 min before the incision of the first two surgeries. The primary outcome will be the occurrence of postoperative infections defined as postoperative sepsis and/or surgical site infection and/or graft lysis requiring a new graft within 7 days after surgery. Secondary outcomes will include mortality at day 90 postrandomization, skin graft lysis requiring a new graft procedure, postoperative bacteremia (within 48 h of surgery), postoperative sepsis, postoperative surgical site infection, number of hospitalizations until complete healing (> 95% TBSA), number of hospitalization days living without antibiotic therapy at day 28 and day 90, and multiresistant bacterial colonization or infection at day 28 and day 90. Discussion: The trial aims to provide evidence on the efficacy and safety of antibiotic prophylaxis for excision-graft surgery in burn patients. Trial registration: ClinicalTrials.gov NCT04292054. Registered on 2 March 2020
- 1 December 2019
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 38 (6) , 631-635
Thiopental versus propofol on the outcome of the newborn after caesarean section: An impact study
- 1 December 2019
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 38 (6) , 631-635
Thiopental versus propofol on the outcome of the newborn after caesarean section: An impact study
- 1 December 2015
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 34 (6) , 367
Right atrial thrombosis: Beware the patent foramen ovale
- 1 December 2015
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 34 (6) , 367
Right atrial thrombosis: Beware the patent foramen ovale
- 1 November 2014
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 100 (7) , 767-773
Chronic pain 1 year after foot surgery: Epidemiology and associated factors
- 1 November 2014
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 100 (7) , 767-773
Chronic pain 1 year after foot surgery: Epidemiology and associated factors
- 1 April 2014
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 33 (4) , e67-e72
A survey of percutaneous chest drainage practice in French university surgical ICU's
- 1 April 2014
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 33 (4) , e67-e72
A survey of percutaneous chest drainage practice in French university surgical ICU's
- 1 October 2013
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 99 (6) , 667-673
Tranexamic acid decreases risk of haematomas but not pain after hip arthroplasty
- 1 October 2013
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 99 (6) , 667-673
Tranexamic acid decreases risk of haematomas but not pain after hip arthroplasty
- 1 September 2013
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 32, A141-A142
L’acide tranéxamique diminue les hématomes mais pas les douleurs après arthroplastie de hanche
- 1 September 2013
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 32, A141-A142
L’acide tranéxamique diminue les hématomes mais pas les douleurs après arthroplastie de hanche
- 1 April 2013
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 99 (2) , 169-174
Nefopam after total hip arthroplasty: Role in multimodal analgesia
- 1 April 2013
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 99 (2) , 169-174
Nefopam after total hip arthroplasty: Role in multimodal analgesia
- Open Access
- 1 June 2012
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 108 (6) , 1042-1043
Ultrasound-guided nerve blocks in the Charcot–Marie–Tooth disease and Friedreich’s ataxia
Editor—Peripheral nerve blocks (PNBs) are of concern in patients with underlying neurological disease.1 The response to electrical stimulation may be impaired, increasing the risk of nerve damage.1 The use of ultrasound has been described only in one case of neurofibromatosis.2 We describe here the use of ultrasound-guided PNBs in hypertrophic peripheral neuropathy [Charcot–Marie–Tooth disease type 1 (CMTD1)] and degenerative disease [Friedreich's ataxia (FRA)].
- 1 June 2012
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 108 (6) , 1042-1043
Open AccessUltrasound-guided nerve blocks in the Charcot–Marie–Tooth disease and Friedreich’s ataxia
Editor—Peripheral nerve blocks (PNBs) are of concern in patients with underlying neurological disease.1 The response to electrical stimulation may be impaired, increasing the risk of nerve damage.1 The use of ultrasound has been described only in one case of neurofibromatosis.2 We describe here the use of ultrasound-guided PNBs in hypertrophic peripheral neuropathy [Charcot–Marie–Tooth disease type 1 (CMTD1)] and degenerative disease [Friedreich's ataxia (FRA)].